Effects of Schwann cells and donor antigen on long-nerve allograft regeneration

Microsurgery

Volumn 25, Issue 1, 2005, Pages 61-70

  Brenner, Michael J ^a   Lowe III, James B ^a   Fox, Ida K ^a   Mackinnon, Susan E ^a   Hunter, Daniel A ^a   Darcy, Michael D ^b   Duncan, James R ^b   Wood, Patrick ^c   Mohanakumar, Thalachallour ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; CRYOPRESERVATION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MORPHOMETRICS; NERVE GRAFT; NERVE REGENERATION; NERVE TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SCHWANN CELL; SWINE; ULNAR NERVE; ULTRAVIOLET IRRADIATION;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; ISOANTIGENS; LYMPHOCYTE CULTURE TEST, MIXED; MODELS, ANIMAL; NERVE REGENERATION; SCHWANN CELLS; SWINE; SWINE, MINIATURE; TRANSPLANTATION, HOMOLOGOUS; ULNAR NERVE; ULTRAVIOLET RAYS;

EID: 13444257799     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/micr.20083     Document Type: Article

References (57)

1. Mackinnon SE, Hudson AR. Clinical application of peripheral nerve transplantation. Plast Reconstr Surg 1992;90:695-699.
2. Mackinnon SE. Nerve allotransplantation following severe tibial nerve injury. Case report. J Neurosurg 1996;84:671-676.
3. Mackinnon SE, Doolabh VB, Novak CB, Trulock EP. Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg 2001;107:1419-1429.
4. Brenner MJ, Tung TH, Jensen JN, Mackinnon SE. The spectrum of complications of immunosuppression: is the time right for hand transplantation? J Bone Joint Surg [Am] 2002;84:1861-1870.
5. Grand AG, Myckatyn TM, Mackinnon SE, Hunter DA. Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice. J Neurosurg 2002;96:924-932.
6. Atchabahian A, Mackinnon SE, Hunter DA. Cold preservation of nerve grafts decreases expression of ICAM-1 and class II MHC antigens. J Reconstr Microsurg 1999;15:307-311.
7. Evans PJ, Mackinnon SE, Midha R, Wade JA, Hunter DA, Nakao Y, Hare GM. Regeneration across cold preserved peripheral nerve allografts. Microsurgery 1999;19:115-127.
8. Evans PJ, Mackinnon SE, Levi AD, Wade JA, Hunter DA, Nakao Y, Midha R. Cold preserved nerve allografts: changes in basement membrane, viability, immunogenicity, and regeneration. Muscle Nerve 1998;21:1507-1522.
9. Strasberg SR, Mackinnon SE, Genden EM, Bain JR, Purcell CM, Hunter DA, Hay JB. Long-segment nerve allograft regeneration in the sheep model: experimental study and review of the literature. J Reconstr Microsurg 1996;12:529-537.
10. Strasberg SR, Mackinnon SE, Hare GM, Narini PP, Hertl C, Hay JB. Reduction in peripheral nerve allograft antigenicity with warm and cold temperature preservation. Plast Reconstr Surg 1996;97:152-160.
11. Hare GM, Evans PJ, Mackinnon SE, Wade JA, Young AJ, Hay JB. Phenotypic analysis of migrant, efferent lymphocytes after implantation of cold preserved, peripheral nerve allografts. J Neuroimmunol 1995;56:9-16.
12. Mosahebi A, Fuller P, Wiberg M, Terenghi G. Effect of allogeneic Schwann cell transplantation on peripheral nerve regeneration. Exp Neurol 2002;173:213-223.
13. Evans GR, Brandt K, Katz S, Chauvin P, Otto L, Bogle M, Wang B, Meszlenyi RK, Lu L, Mikos AG, Patrick CW Jr. Bioactive poly (L-lactic acid) conduits seeded with Schwann cells for peripheral nerve regeneration. Biomaterials 2002;23:841-848.
14. Mosahebi A, Woodward B, Wiberg M, Martin R, Terenghi G. Retroviral labeling of Schwann cells: in vitro characterization and in vivo transplantation to improve peripheral nerve regeneration. Glia 2001;34:8-17.
15. Ogden MA, Feng FY, Myckatyn TM, Jensen JN, Grand AG, Wood PW, Hunter DA, Mackinnon SE. Safe injection of cultured schwann cells into peripheral nerve allografts. Microsurgery 2000;20:314-323.
16. Rodriguez FJ, Verdu E, Ceballos D, Navarro X. Nerve guides seeded with autologous schwann cells improve nerve regeneration. Exp Neurol 2000;161:571-584.
17. Ansselin AD, Fink T, Davey DF. Peripheral nerve regeneration through nerve guides seeded with adult Schwann cells. Neuropathol Appl Neurobiol 1997;23:387-398.
18. Mosahebi A, Fuller P, Wiberg M, Terenghi G. Effect of allogeneic Schwann cell transplantation on peripheral nerve regeneration. Exp Neurol 2002;173:213-223.
19. Evans GR, Brandt K, Katz S, Chauvin P, Otto L, Bogle M, Wang B, Meszlenyi RK, Lu L, Mikos AG, Patrick CW Jr. Bioactive poly (L-lactic acid) conduits seeded with Schwann cells for peripheral nerve regeneration. Biomaterials 2002;23:841-848.
20. Fansa H, Dodic T, Wolf G, Schneider W, Keilhoff G. Tissue engineering of peripheral nerves: epineurial grafts with application of cultured Schwann cells. Microsurgery 2003;23:72-77.
21. Schlosshauer B, Muller E, Schroder B, Planck H, Muller HW. Rat Schwann cells in bioresorbable nerve guides to promote and accelerate axonal regeneration. Brain Res 2003;963:321-326.
22. Yu S, Nakafusa Y, Flye MW. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance. Surgery 1994;116:229-234.
23. Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D, Cruz PD Jr. Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J Immunol 1991;146:485-491.
24. Simon JC, Cruz PD Jr, Bergstresser PR, Tigelaar RE. Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset. J Immunol 1990;145:2087-2091.
25. Deeg HJ, Sigaroudinia M. Ultraviolet B-induced loss of HLA class II antigen expression on lymphocytes is dose, time, and locus dependent. Exp Hematol 1990;18:916-919.
26. Kamei T, Callery MP, Flye MW. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival. Surgery 1990;108:415-421.
27. Wrenshall LE, Ansite JD, Eckman PM, Heilman MJ, Stevens RB, Sutherland DE. Modulation of immune responses after portal venous injection of antigen. Transplantation 2001;71:841-850.
28. Carr RI, Zhou J, Ledingham D, Maloney C, McAlister V, Samson M, Bitter-Suermann H, Lee TD. Induction of transplantation tolerance by feeding or portal vein injection pretreatment of recipient with donor cells. Ann NY Acad Sci 1996;778:368-370.
29. Atchabahian A, Genden EM, Mackinnon SE, Doolabh VB, Hunter DA. Regeneration through long nerve grafts in the swine model. Microsurgery 1998;18:379-382.
30. Casella GT, Wieser R, Bunge RP, Margitich IS, Katz J, Olson L, Wood PM. Density dependent regulation of human Schwann cell proliferation. Glia 2000;30:165-177.
31. Levi AD, Sonntag VK, Dickman C, Mather J, Li RH, Cordoba SC, Bichard B, Berens M. The role of cultured Schwann cell grafts in the repair of gaps within the peripheral nervous system of primates. Exp Neurol 1997;143:25-36.
32. Levi AD, Bunge RP. Studies of myelin formation after transplantation of human Schwann cells into the severe combined immunodeficient mouse. Exp Neurol 1997;130:41-52.
33. Mackinnon SE, Hudson AR, Hunter DA. Histologic assessment of nerve regeneration in the rat. Plast Reconstr Surg 1985;75:384-388.
34. Bunge RP, Bunge MB, Eldridge CF. Linkage between axonal ensheathment and basal lamina production by Schwann cells. Annu Rev Neurosci 1986;9:305-328.
35. Bunge RP. Expanding roles for the Schwann cell: ensheathment, myelination, trophism and regeneration. Curr Opin Neurobiol 1993;3:805-809.
36. Bunge RP. The role of the Schwann cell in trophic support and regeneration. J Neurol 1994;242:19-21.
37. Levi AD, Guenard V, Aebischer P, Bunge RP. The functional characteristics of Schwann cells cultured from human peripheral nerve after transplantation into a gap within the rat sciatic nerve. J Neurosci 1994;14:1309-1319.
38. Yu LT, Rostami A, Silvers WK, Larossa D, Hickey WF. Expression of major histocompatibility complex antigens on inflammatory peripheral nerve lesions. J Neuroimmunol 1990;30:121-128.
39. Midha R, Mackinnon SE, Becker LE. The fate of Schwann cells in peripheral nerve allografts. J Neuropathol Exp Neurol 1994;53:316-322.
40. Fox IK, Mackinnon SE, Jaramillo A., Rickman SE, Hunter DA. Prolonged cold preservation of nerve allografts yields a non-immunogenic graft. Muscle Nerve 2004; submitted.
41. Rao VK, Burris DE, Gruel SM, Sollinger HW, Burlingham WJ. Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allografts in rats. Transplantation 1988;45:1145-1146.
42. Genden EM, Mackinnon SE, Yu S, Hunter DA, Flye MW. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts. Laryngoscope 2001;111:439-447.
43. Weiss JM, Renkl AC, Denfeld RW, de Roche R, Spitzlei M, Schopf E, Simon JC. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells. Eur J Immunol 1995;25:2858-2862.
44. Pretell JO, Cone RE. Comparison of altered expression of histocompatibility antigens with altered immune function in murine spleen cells treated with ultraviolet radiation and/or TPA. Transplantation 1985;39:175-181.
45. Levin D, Gershon H. Interleukin production by neonatal spleen cells during and as a result of antigen presentation: the effect of ultraviolet light. Lymphokine Res 1989;8:185-201.
46. Kremer IB, Hilkens CM, Sylva-Steenland RM, Koomen CW, Kapsenberg ML, Bos JD, Teunissen MB. Reduced IL-12 production by monocytes upon ultraviolet-B irradiation selectively limits activation of T helper-1 cells. J Immunol 1996;157: 1913-1918.
47. Yu S, Tu Y, Flye MW. The shift of Th1/Th2 ratios induced by portal venous administration of UVB-treated donor spleen cells prolonged mouse cardiac allografts. Transplant Proc 1997;29:1162.
48. Kripke ML. Immunological unresponsiveness induced by ultraviolet radiation. Immunol Rev 1984;80:87-102.
49. Kripke ML. Ultraviolet radiation and immunology: something new under the sun-presidential address. Cancer Res 1994;54:6102-6105.
50. Qian JH, Kokudo S, Sato S, Hamaoka T, Fujiwara H. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection. Transplantation 1987;43:538-543.
51. Hamashima T, Yoshimura N, Matsui S, Lee CJ, Ohsaka Y, Oka T. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. II. Phenotypic and functional analyses of graft-infiltrating cells. Transplantation 1990;49:171-175.
52. Nakagawa K, Matsuno T, Haisa M, Fujiwara T, Ishido N, Tanaka N, Orita K. Induction of MLR hyporesponsiveness after portal venous inoculation with donor splenocytes correlates with persistence of donor lymphocytes in host organs. Transplant Proc 1996;28:1295-1297.
53. Shiratori Y, Okano K, Matsumoto K, Murao S. Antigen presentation by Kupffer cells in the rat. Scand J Gastroenterol 1984;19:733-739.
54. Kenick S, Lowry RP, Forbes RD, Lisbona R. Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: what is "hepatic tolerance? Transplant Proc 1987;19:478-480.
55. Callery MP, Kamei T, Flye MW. Kupffer cell blockade inhibits induction of tolerance by the portal venous route. Transplantation 1989;47:1092-1094.
56. Kamei T, Callery MP, Flye MW. Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation. J Surg Res 1990;48:393-396.
57. Lowry RP, Kenick S, Lisbona R. Speculation on the pathogenesis of prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells. Transplant Proc 1987;19:3451-3453.